Membership Overview
Browsing articles in "ADHD"

 

New Stimulant Formulations Approved for ADHD
June 23, 2017   

The FDA has approved two new stimulant formulations for the treatment of attention deficit hyperactivity disorder (ADHD)...
 Continue reading (Members only)
Highlights from the 2017 APA Annual Meeting
June 8, 2017   

The 2017 APA annual meeting, held in NEI's hometown of San Diego, was themed "Prevention Through Partnership" and included more than 400 sessions. Here, we provide highlights of the meeting, including NEI's podcast interviews with expert presenters, key research from the poster sessions, and NEI's debut live concert--the NEI PsychopharmaJam.
 Continue reading
Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading (Members only)
New Brief Screening Tool for Adult ADHD
May 9, 2017   

Researchers affiliated with the World Health Organization (WHO) have developed a brief scale that can reliably screen for attention-deficit/hyperactivity disorder in most adults — using just six straight forward questions...
 Continue reading (Members only)
Long-Term Stimulant Use and Growth: Interpretation of Results from the MTA Follow-Up
April 25, 2017   

In a study that followed more than 500 children with attention-deficit/hyperactivity disorder (ADHD) into adulthood, extended use of stimulant medication was linked with....
 Continue reading (Members only)
Brain Volume Differences in ADHD
March 3, 2017   

In a recent mega analysis study, researchers found that MRI scans showed that people diagnosed with attention deficit hyperactivity disorder (ADHD) have slightly smaller overall brain volume than people without ADHD...
 Continue reading (Members only)
Stimulant Use and Bone Mass in Children and Adolescents
April 13, 2016   

In an abstract by Feuer et al. presented at the Endocrine Society 2016, a cross-sectional analysis was conducted on data collected from 6489 (8-20 years old) participants to explore associations between stimulant medications and bone mass in pediatric patients. Dual-energy X-ray absorptiometry (DXA) was used to measure...
 Continue reading (Members only)
February News and New Research
February 1, 2016   

ABPN updates MOC Part IV requirements yet again, RAISE data show cost-effectiveness of coordinated specialty care for first-episode psychosis, FDA grants breakthrough therapy designation for IV NMDA receptor agonist in treatment-resistant depression, and other news.
 Continue reading (Members only)
December News and New Research
December 1, 2015   

DNA methylation in early neurodevelopment may confer risk for schizophrenia, expert consensus statements for inpatient care of children with autism or intellectual disabilities, approval of first chewable extended release tablet for ADHD, and other news.
 Continue reading (Members only)
June News and New Research
June 1, 2015   

LAI risperidone superior to oral risperidone in first-episode psychosis, Daytrana patch may cause permanent skin color loss, depression as a prodromal symptom of Parkinson's disease, and other news.
 Continue reading (Members only)
12
Top of Page